HC Wainwright Reiterates Buy Rating for Cabaletta Bio (NASDAQ:CABA)
Cabaletta Bio (NASDAQ:CABA – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research note issued on Wednesday,Benzinga reports. They presently have a $25.00 target price on the stock. A number of other research firms have also recently commented on CABA. Wells Fargo & Company lowered their […]
Cabaletta Bio (NASDAQ:CABA – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research note issued on Wednesday,Benzinga reports. They presently have a $25.00 target price on the stock. A number of other research firms have also recently commented on CABA. Wells Fargo & Company lowered their […]
